Industries > Pharma > Pharma Wholesale and Distribution Market Forecasts 2020-2030

Pharma Wholesale and Distribution Market Forecasts 2020-2030

Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW

PUBLISHED: 30 September 2019
PAGES: 217
PRODUCT CODE: PHA0526

Clear
WOOCS 2.2.1

The pharma wholesale and distribution market is estimated to grow at a CAGR of 5% in the first half of the forecast period. The market is estimated to reach a revenue of $1,447bn in 2025. In 2018, the branded drugs submarket held 78% of the pharma wholesale and distribution market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 217-page report you will receive 135 charts– all unavailable elsewhere.

The 217-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharma Wholesale and Distribution Market from 2020-2030

• Forecast of the Global Pharma Wholesale and Distribution market by Category:
• Generic Drugs
• Branded Drugs
• Others

• This report provides individual revenue forecasts to 2030 for these national markets:
• US
• Germany
• France
• Italy
• Spain
• UK
• Japan
• China
• Brazil
• India
• Russia
• RoW

Pharma Wholesale and Distribution Market Forecasts 2020-2030

Each National Market is further segmented into generic drugs, branded drugs and others

• Our study discusses the selected leading companies that are the major players in the global pharma and wholesale distribution market:
• Alfresa Holdings
• AmerisourceBergen
• Cardinal Health
• CR Pharmaceuticals
• CuraScript SD
• McKesson
• Medipal Holdings Corporation
• Morris and Dickson
• Mutual Drug Company
• PHOENIX Group
• Shanghai Fosun Pharmaceuticals
• Sinopharm
• Suzuken
• Walgreens Boots Alliance

• This report provides a SWOT and STEP analysis of the pharma wholesale and distribution market.

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma wholesale and distribution market. You find data, trends and predictions.

Buy our report today Pharma Wholesale and Distribution Market Forecasts 2020-2030: Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2020-2030


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories